Showing results (41-50 of 318) with videos related to

Sort By:
Pageof 32
Cells|March 7, 2020
Immunotherapy in Multiple MyelomaCinnie Yentia Soekojo, Melissa Ooi, Sanjay de Mel, et al.
World Journal of Gastroenterology|January 10, 2015
P53 mutations in colorectal cancer - molecular pathogenesis and pharmacological reactivationXiao-Lan Li, Jianbiao Zhou, Zhi-Rong Chen, et al.
Cancer Control : Journal of the Moffitt Cancer Center|April 28, 2005
Targeted therapy in multiple myelomaWee Joo Chng, Lee Gong Lau, Noorainun Yusof, et al.
Biomolecules|September 23, 2022
Molecular Determinants Underlying the Anti-Cancer Efficacy of CD38 Monoclonal Antibodies in Hematological MalignanciesNurulhuda Mustafa, Muhamad Irfan Azaman, Giselle G K Ng, et al.
Expert Review of Pharmacoeconomics & Outcomes Research|December 14, 2021
Cost-effectiveness of daratumumab in combination with lenalidomide and dexamethasone for relapsed and/or refractory multiple myelomaXin Yi Wong, Wee Joo Chng, Mohamed Ismail Abdul Aziz, et al.
Cancers|September 16, 2018
The Role of Signal Transducer and Activator of Transcription 3 (STAT3) and Its Targeted Inhibition in Hematological MalignanciesLoukik Arora, Alan Prem Kumar, Frank Arfuso, et al.
Biomed Research International|August 8, 2014
Implications of heterogeneity in multiple myelomaSanjay de Mel, Su Hong Lim, Moon Ley Tung, et al.
Haematologica|July 16, 2026
Risk factors and their contributions to prognosis in multiple myelomaTae-Hoon Chung, Jia Geng Chang, Tze King Tan, et al.
Blood Cancer Journal|February 1, 2022
Genomic characterization of functional high-risk multiple myeloma patientsCinnie Yentia Soekojo, Tae-Hoon Chung, Muhammad Shaheryar Furqan, et al.
Cancers|November 26, 2022
Tumor-Associated Macrophages and Related Myelomonocytic Cells in the Tumor Microenvironment of Multiple MyelomaSamuel S Y Wang, Wee Joo Chng, Haiyan Liu, et al.
Pageof 32